Testosterone-propionate/testosterone-phenylpropionate/testosterone-isocaproate/testosterone-decanoate: Myocardial infarction.

Author InformationAn event is serious (based on the ICH definition) when the patient outcome is:• * death * life-threatening * hospitalisation * disability * congenital anomaly * other medically important eventA 31-year-old transgender man (female to male) patient developed myocardial infarction while receiving hormonal therapy with testosterone-propionate/testosterone-phenylpropionate/testosterone-isocaproate/testosterone-decanoate for gender transformation. [Extracted from the article]